PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 9 months ago Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases Financial Results Webcast Immunic Inc. Q2 2024 Inflammatory Diseases
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 9 months ago Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results Financial Framework Moderna Business Updates Q2 Revenues Vaccine Approvals
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 9 months ago Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals Conference Call Zomedica Corp. Veterinary Health Animals Q2 2024 Financial Results
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 9 months ago "NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides NanoViricides, Inc., reports on independent research highlighting NV-387's broad-spectrum action in viral therapy, potentially revolutionizing antiviral treatment strategies NV-387 NanoViricides Inc. Antiviral Nanomedicines Broad-spectrum Action Viral Therapy
PRESS RELEASE published on 08/01/2024 at 12:27, 1 year 9 months ago Nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2024 Electricite et Eaux de Madagascar publie sa declaration de capital et droits de vote conformement au Reglement General de l'Autorite des Marches Financiers Autorité Des Marchés Financiers Droits De Vote Règlement Général Electricité Et Eaux De Madagascar Declaration De Capital
PRESS RELEASE published on 08/01/2024 at 12:16, 1 year 9 months ago Total Voting Rights M&G Credit Income Investment Trust plc announces total voting rights as of 31 July 2024 per FCA rules M&G Credit Income Investment Trust Plc Total Voting Rights Transparency Rules Financial Conduct Authority Disclosure Guidance
PRESS RELEASE published on 08/01/2024 at 12:00, 1 year 9 months ago SUN.io Launches SUN DAO to Enhance Decentralized Governance and Drive Ecosystem Innovation SUN.io launches SUN DAO, a decentralized governance initiative on TRON blockchain, enhancing community autonomy and protocol governance. SUN DAO to revolutionize DeFi governance, incentivizing active participation and innovation Decentralized Governance DeFi SUN.io TRON Blockchain SUN DAO
PRESS RELEASE published on 08/01/2024 at 11:30, 1 year 9 months ago Iute Group reports unaudited 6M 2024 results on 22 August 2024 – Invitation to earnings webcast/call on the same day Iute Group invites investors to webcast/call on 22 August 2024 to discuss unaudited 6M 2024 results. CEO and CFO to present in English Investors Webcast Earnings Call Iute Group 6M 2024 Results
PRESS RELEASE published on 08/01/2024 at 11:30, 1 year 9 months ago Renewi plc: Holding(s) in Company Renewi plc reports major holdings notification by Avenue Europe International Management, L.P. on 29/07/2024. Details of voting rights and shareholders disclosed Shareholders Voting Rights Major Holdings Notification Renewi Plc Avenue Europe International Management
PRESS RELEASE published on 08/01/2024 at 11:20, 1 year 9 months ago MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory MindBio Therapeutics appoints Haywood Securities Inc. as strategic advisor to support investment initiatives. Company progressing with Phase 2B clinical trials for psychedelic medicine MB22001 Psychedelic Medicine Clinical Trials Investment MindBio Therapeutics Haywood Securities Inc.
Published on 05/02/2026 at 21:00, 9 hours 2 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 4 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 5 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 6 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 6 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 1 hour 16 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 14 hours 26 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 21:21, 2 days 8 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 10 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 10 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 10 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 10 hours ago AXA annonce les résultats de son Assemblée Générale